SK Bioscience works with global partners on Bundibugyo Ebola vaccine development and production
Predicted impact: Medium
₩131B project is about 20% of revenue, but the same news was already reported.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.